Dr. Mark B. Berger – President and Chief Medical Officer

Dr. Mark B. BergerDr. Mark Berger was born in Houston and attended the University of Texas where he graduated with highest honors. He then studied medicine at Baylor College of Medicine, graduating with honors and as a member of the Alpha Omega Alpha Medical Honor Society. He has been a licensed physician in Texas since 1981 and is Board Certified in Sleep Medicine, as well as Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. In the late 1980s while serving as an Assistant Professor of Medicine at Baylor College of Medicine, Dr. Berger was a member of one of the first lung transplant teams in the United States. He was one of the first individuals in the United States to implant metallic bronchial stents into the airways of lung transplant recipients suffering from post-transplant bronchial narrowing. In the 1990s, Dr. Berger entered private practice at The Methodist Hospital in Houston, Texas, where he cared for thousands of pulmonary and critically ill individuals. He served briefly as Assistant Director of Hyperbaric Medicine at Methodist Hospital and for seven years he was Chief of Staff at Select Specialty Hospital in Houston. In the early 2000s, Dr. Berger became one of only 450 physicians in the country holding a B-Reader certification for specialized interpretation of chest x-rays in asbestos-and silica-exposed individuals. He was widely sought out as an expert medical witness in hundreds of occupational inhalation exposure cases. Additionally, Dr. Berger’s interest and expertise in sleep medicine developed during this time. He was the Medical Director for a Houston SleepMed testing center where he treated over 1,000 patients for sleep apnea.

In 2003, Dr. Berger created PPD and began working as a consultant to Schneider National. In that capacity he worked closely in developing their sleep apnea program for drivers. This program includes the first-ever fleet-wide screening of drivers for sleep apnea. His experience with Schneider National has been reported as one of four “outstanding papers” chosen at the 2005 International Truck and Bus Safety and Security Symposium, sponsored by the Federal Motor Carrier Safety Administration and the American Trucking Association. Schneider National was awarded the National Sleep Foundation’s 2007 Healthy Sleep Community Award in recognition of the PPD-developed program implemented there. Dr. Berger’s research interests currently include on going collaborative work with Virginia Tech Transportation Institute, the University of Minnesota, and Harvard University. Dr. Berger is President and Chief Medical Officer for PPD and has overseen the screening of nearly 38,000 commercial drivers and the diagnosis and treatment of sleep apnea in nearly 4,500 CDL holders. He holds a U.S. Patent for his unique sleep apnea disease management program for commercial drivers and the SomniSage sleep apnea screening questionnaire as well as several other patents pending. PPD currently provides a comprehensive sleep apnea program for Schneider National, Swift Transportation, and H.O. Wolding Transportation. Several other large carriers are planning projects with PPD for 2013. PPD’s program is the only sleep apnea program that has generated proven generous returns on investment for its clients. Dr. Berger’s approach to remedying the problems associated with sleep apnea in commercial drivers combines solid evidence-based medical research with a unique sensitivity to the specific demands and requirements of the trucking industry.

Please contact Dr. Berger here.